Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trivalent ions kinetic-gating for producing high-concentration and shelf-stable plasmid DNA/PEI particles.

Nature communications·2026
Same author

Quantitative analysis of sequential nucleic acid elution from silica paramagnetic beads.

The Analyst·2026
Same author

A Multiplex Digital Polymerase Chain Reaction-Based Platform with a Unified Readout for Multiclass Biomarker Quantification from Low-Volume Blood.

ACS nano·2026
Same author

An unbiased approach to measure aberrant DNA methylation alterations.

Nature communications·2026
Same author

Rapid Bacteria Identification and Antimicrobial Susceptibility Testing via 5-Min Fluorescence In Situ Hybridization.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Buffer Valency Engineering Enables High-concentration and Shelf-stable DNA Transfection Particles for Viral Vector Production.

Research square·2025

Related Experiment Video

Updated: Oct 7, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.6K

Combinatorial nanodroplet platform for screening antibiotic combinations.

Hui Li1, Pengfei Zhang2, Kuangwen Hsieh1

  • 1Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD, USA. thwang@jhu.edu.

Lab on a Chip
|January 11, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a novel nanodroplet platform for rapid, low-reagent screening of antibiotic combinations. This technology aids in combating multidrug-resistant bacteria by optimizing personalized antibiotic therapies.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

8.0K

Related Experiment Videos

Last Updated: Oct 7, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.6K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

8.0K

Area of Science:

  • Biotechnology
  • Microbiology
  • Drug Discovery

Background:

  • Multidrug-resistant bacteria and dwindling effective antibiotics present global health challenges.
  • Personalized antibiotic treatments require rapid diagnostics and novel therapeutic strategies.
  • Combinatorial antibiotic therapies show promise but face screening complexities and high costs.

Purpose of the Study:

  • To develop an automated, high-throughput combinatorial nanodroplet platform for antibiotic screening.
  • To reduce reagent consumption significantly compared to traditional methods.
  • To enable flexible and sensitive biochemical assays for evaluating antibiotic combinations.

Main Methods:

  • Development of a combinatorial nanodroplet platform for automated reagent mixing and concentration tuning.
  • Implementation of a resazurin-based biochemical assay to monitor bacterial metabolism.
  • High-throughput screening of pairwise antibiotic combinations using the nanodroplet platform.

Main Results:

  • The nanodroplet platform demonstrated automated creation of nanoliter droplets with multiple reagents.
  • The platform enabled flexible assay conditions (temperature, duration) and sensitive detection.
  • A pilot study successfully screened pairwise combinations of four antibiotics against *Escherichia coli*.

Conclusions:

  • The developed nanodroplet platform offers a cost-effective and efficient solution for screening antibiotic combinations.
  • This technology can accelerate the discovery of effective combinatorial antibiotic therapies.
  • The platform has the potential to advance personalized medicine in the fight against bacterial infections.